Symbiotec Pharmalab Financials
NSE: SYMBIOTEC | BSE: 544889
₹1,149.50
₹-20.20
(-1.73%)
As on 06-Oct-2026IST
Market cap
₹7,389 Cr
Revenue (TTM)
₹869 Cr
P/E Ratio
67.2
P/B Ratio
4.9
Div. Yield
0 %
Income Statement (₹ Cr) |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
869.15
|
751.55
|
716.25
|
566.51
|
681.80
|
632.90
|
|
|
|
|
|
|
Total Income
|
872.26
|
755.98
|
723.33
|
572.97
|
684.79
|
639.93
|
|
|
|
|
|
|
Total Expenditure
|
630.48
|
548.84
|
544.20
|
496.97
|
550.36
|
438.12
|
|
|
|
|
|
|
EBITDA
|
238.67
|
202.72
|
172.05
|
69.54
|
131.44
|
194.79
|
|
|
|
|
|
|
Depreciation
|
53.28
|
43.10
|
38.82
|
28.52
|
25.83
|
22.47
|
|
|
|
|
|
|
EBIT
|
185.39
|
159.62
|
133.23
|
41.02
|
105.61
|
172.31
|
|
|
|
|
|
|
Interest
|
26.14
|
16.91
|
7.96
|
8.14
|
3.14
|
6.79
|
|
|
|
|
|
|
Other Income
|
3.11
|
4.43
|
7.09
|
6.46
|
3.00
|
7.03
|
|
|
|
|
|
|
Exceptional Items
|
-8.99
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
153.36
|
146.98
|
130.98
|
38.27
|
105.47
|
172.55
|
|
|
|
|
|
|
Provision for Tax
|
43.46
|
50.19
|
30.93
|
14.78
|
28.18
|
48.39
|
|
|
|
|
|
|
Profit after Tax
|
109.90
|
96.79
|
100.06
|
23.49
|
77.29
|
124.16
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Share of Associate
|
--
|
--
|
--
|
--
|
0.24
|
-0.88
|
|
|
|
|
|
|
Consolidated Profit
|
109.90
|
96.79
|
100.06
|
23.49
|
77.53
|
123.28
|
|
|
|
|
|
Liabilities (₹ Cr) |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,149.73
|
814.89
|
715.05
|
621.53
|
598.70
|
520.53
|
|
|
|
|
|
|
Minority Interest
|
-0.14
|
-0.19
|
-0.21
|
-0.09
|
-0.11
|
0.04
|
|
|
|
|
|
|
Non-Current Liabilities
|
103.64
|
292.35
|
228.73
|
140.48
|
27.89
|
23.12
|
|
|
|
|
|
|
Current Liabilities
|
527.57
|
472.60
|
351.21
|
228.07
|
188.70
|
224.53
|
|
|
|
|
|
|
Total Liabilities
|
1,780.79
|
1,579.65
|
1,294.79
|
989.99
|
815.18
|
768.21
|
|
|
|
|
|
Assets (₹ Cr) |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
1,295.25
|
1,086.79
|
786.58
|
589.82
|
389.71
|
344.77
|
|
|
|
|
|
|
Current Assets
|
485.54
|
492.86
|
508.21
|
400.17
|
425.46
|
423.44
|
|
|
|
|
|
|
Total Assets
|
1,780.79
|
1,579.65
|
1,294.79
|
989.99
|
815.18
|
768.21
|
|
|
|
|
|
|
Total Debt*
|
387.91
|
540.92
|
247.21
|
217.88
|
64.66
|
47.42
|
|
|
|
|
|
|
Net Current Assets
|
-42.02
|
20.26
|
157.00
|
172.10
|
236.77
|
198.92
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
--
|
1.15
|
--
|
1.13
|
--
|
|
|
|
|
|
Cashflow (₹ Cr) |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
174.59
|
47.26
|
187.50
|
69.24
|
17.71
|
174.33
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
-226.93
|
-306.52
|
-206.41
|
-219.99
|
-31.64
|
-96.35
|
|
|
|
|
|
|
Cash from Financing Activities
|
35.99
|
278.16
|
21.85
|
146.14
|
15.14
|
-79.28
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
-16.35
|
18.90
|
2.94
|
-4.61
|
1.21
|
-1.30
|
|
|
|
|
|
Financials Ratios |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
17.52
|
17.70
|
18.30
|
4.30
|
14.18
|
22.55
|
|
|
|
|
|
|
Cash EPS (₹)
|
26.01
|
25.58
|
25.40
|
9.51
|
18.86
|
26.82
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
183.16
|
148.24
|
130.77
|
113.67
|
109.49
|
95.20
|
|
|
|
|
|
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
27.83
|
43.21
|
171.45
|
63.31
|
16.20
|
159.41
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
-10.36
|
-269.77
|
-19.41
|
-144.80
|
-49.49
|
66.47
|
|
|
|
|
|
Profitability Ratios |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
12.41
|
14.14
|
15.42
|
6.18
|
17.64
|
33.04
|
|
|
|
|
|
|
ROE (%)
|
11.22
|
12.69
|
14.97
|
3.85
|
13.81
|
27.06
|
|
|
|
|
|
|
ROA (%)
|
6.54
|
6.73
|
8.76
|
2.60
|
9.76
|
17.19
|
|
|
|
|
|
|
EBIT Margin (%)
|
21.33
|
21.24
|
18.60
|
7.24
|
15.49
|
27.23
|
|
|
|
|
|
|
Net Margin (%)
|
12.60
|
12.80
|
13.83
|
4.10
|
11.29
|
19.40
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
18.57
|
18.39
|
19.20
|
9.04
|
15.12
|
23.17
|
|
|
|
|
|
Growth Ratios |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
15.65
|
4.93
|
26.43
|
-16.91
|
7.73
|
19.31
|
|
|
|
|
|
|
EBIT Growth (%)
|
16.14
|
19.81
|
224.78
|
-61.16
|
-38.71
|
117.55
|
|
|
|
|
|
|
Net Profit Growth (%)
|
13.55
|
-3.27
|
326.02
|
-69.61
|
-37.75
|
135.28
|
|
|
|
|
|
|
EPS Growth (%)
|
-1.03
|
-3.27
|
326.02
|
-69.71
|
-37.11
|
157.54
|
|
|
|
|
|
|
Book Value Growth (%)
|
41.75
|
13.36
|
15.05
|
3.81
|
15.02
|
31.11
|
|
|
|
|
|
Valuation Ratios |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Price / Book Value
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
EV/EBITDA
|
1.61
|
2.54
|
1.40
|
2.94
|
0.48
|
0.05
|
|
|
|
|
|
|
Close Price (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
High Price (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Low Price (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Solvency Ratios |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.34
|
0.67
|
0.35
|
0.35
|
0.11
|
0.09
|
|
|
|
|
|
|
Short term debt to equity ratio
|
0.25
|
0.28
|
0.07
|
0.17
|
0.11
|
0.09
|
|
|
|
|
|
|
Current Ratio
|
0.92
|
1.04
|
1.45
|
1.75
|
2.25
|
1.89
|
|
|
|
|
|
|
Quick Ratio
|
0.47
|
0.49
|
0.49
|
0.69
|
0.95
|
0.88
|
|
|
|
|
|
|
Interest Coverage
|
6.87
|
9.69
|
17.45
|
5.70
|
34.57
|
26.41
|
|
|
|
|
|
Operating Efficiency Ratios |
Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
22.73
|
23.37
|
17.55
|
19.76
|
21.05
|
18.65
|
|
|
|
|
|
|
Asset Turnover
|
0.52
|
0.53
|
0.63
|
0.64
|
0.86
|
0.88
|
|
|
|
|
|
|
Receivable days
|
77.53
|
72.30
|
59.95
|
81.07
|
70.01
|
64.65
|
|
|
|
|
|
|
Inventory Days
|
103.51
|
143.31
|
146.23
|
155.32
|
126.16
|
131.63
|
|
|
|
|
|
|
Payable days
|
131.22
|
193.98
|
178.64
|
109.67
|
104.87
|
153.60
|
|
|
|
|
|
|
Cash Conversion Cycle
|
49.82
|
21.63
|
27.55
|
126.72
|
91.30
|
42.67
|
|
|
|
|
|
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
